- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Human epidermal growth factor receptor 2 (HER-2) positive metastatic breast cancer
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Paclitaxel - nanoparticle albumin bound (nab-paclitaxel) – November 2015
Paclitaxel – Nanoparticle albumin bound (Nab-Paclitaxel): nanoparticle albumin bound 100 mg injection, 1 x 100 mg vial, Abraxane®
Last updated
18 March 2016